All Blog Posts Tagged 'CFAK-C4' (2)

Novel FAK Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density

Pre-clinical research results presented at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer in Barcelona, Spain shows that novel Focal Adhesion Kinase (FAK) inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) decrease pancreatic cancer tumor blood flow and reduce blood vessel density in vivo. The research was conducted by scientists of… Continue

Added by Peter Hofland, PhD on June 23, 2011 at 5:30pm — No Comments

Orphan Drug Designation for FAK Inhibitor in Treatment of Pancreatic Cancer

Focal Adhesion Kinase (FAK), a member of a family of nonreceptor protein-tyrosine kinases, is substantially over-expressed in many cancers, including breast, thyroid, prostate, colon, cervical, ovarian, liver and pancreatic cancer [1, 2]. FAK operates by placing itself at the contact points between tumor cells and the extra cellular matrix that surrounds them.



Researchers have found that FAK is an important facilitator for signals that cause tumor cells to…

Continue

Added by Peter Hofland, PhD on January 18, 2011 at 3:30pm — No Comments

ADVERTISEMENT

Onco'Zine is present here

© 2013   Created by Peter Hofland, PhD.

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+